Aerie Pharma (AERI) Misses Q3 EPS by 7c
Tweet
Share
E-mail
Get Alerts AERI Hot Sheet
Join SI Premium – FREE
Aerie Pharma (NASDAQ: AERI) reported Q3 EPS of ($0.71), $0.07 worse than the analyst estimate of ($0.64).
For earnings history and earnings-related data on Aerie Pharma (AERI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
- Autodesk (ADSK) Tops Q2 EPS by 18c, Beats on Revenue; Offers FY27 EPS Guidance
- The Gap, Inc. (GAP) Tops Q2 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
